Skip to main content
Clinical Trials/CTRI/2024/03/063748
CTRI/2024/03/063748Not yet recruitingNot Applicable

A clinical study on application of therapeutics of fever by H C Allen in management of pyrexia of unknown origin among paediatric age group

Sarada Krishna Homoeopathic medical college1 site in 1 country15 target enrollmentStarted: March 15, 2024Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
15
Locations
1
Primary Endpoint
Patients with pyrexia of unknown origin is taken using fever assessment scale and treatment with homoeopathic medicine after repertorization with Therapeutics of fever by H C Allen

Study Overview

Brief Summary

Fever is a state of elevated core temperature that is frequently, but not always, a component of the defensive responses of multicellular organisms (host) to the invasion of live (microorganisms) or inanimate matter recognized as pathogenic or alien by the host. Fever is one of the earliest clinical indications of disease in the mammalian host and one of the leading causes of medical consultations globally. The endocrine, neurological, Immunological, and behavioral systems that control the multi-systemic effects of the febrile response may be responsible for its complexity. In addition to a controlled rise in body temperature, fever is also accompanied by a variety of illness-related behaviors, modifications to the physiological and metabolic makeup of many bodily systems, and changes to immunological responses. Fever of unknown origin (FUO) is defined as fever & more than 101 °C Lasting for 3 weeks or more for which no cause is apparent After 1 week of outpatient investigation. A practical definition is fever & more than 101 °F measured on several occasions over a 7-day period. Febrile illness in children is a major concern to the parents and requires prompt intervention. The conventional treatment has ill effects since it uses many drugs to treat the illness and it is also not favored by the child. But homoeopathic management treats the same illness with a single, minimal dose medicine and is also easily consumed by the child which makes it children friendly. The purpose of this study is to effectively manage pyrexia of unknown origin in children using therapeutics of fever by H.C.Allen.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
1.00 Year(s) to 18.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • Children of both sexes with pyrexia of unknown origin with in age limit of 1 year to 18 years from Sarada Krishna homoeopathic medical college is taken using fever assessment scale.

Exclusion Criteria

  • Children undertaking other system of medicine and with some other deep pathology is excluded Children under 1 year and above 18 years are also excluded.

Outcomes

Primary Outcomes

Patients with pyrexia of unknown origin is taken using fever assessment scale and treatment with homoeopathic medicine after repertorization with Therapeutics of fever by H C Allen

Time Frame: 1 year

Secondary Outcomes

  • pyrexia of unknown origin is treated with homoeopathic medicine on repertorizing with therapeutics of fever by H C Allen(1 year)

Investigators

Sponsor
Sarada Krishna Homoeopathic medical college
Sponsor Class
Private medical college
Responsible Party
Principal Investigator
Principal Investigator

Dr Shalini N

Sarada Krishna Homoeopathic medical college

Study Sites (1)

Loading locations...

Similar Trials